在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

FASN Recombinant Monoclonal Antibody

  • 中文名稱:
    FASN重組抗體
  • 貨號:
    CSB-RA240595A0HU
  • 規格:
    ¥1320
  • 圖片:
    • Immunofluorescence staining of Hela Cells with CSB-RA240595A0HU at 1:50, counter-stained with DAPI. The cells were fixed in 4% formaldehyde, permeated by 0.2% TritonX-100, and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4℃. Nuclear DNA was labeled in blue with DAPI. The secondary antibody was FITC-conjugated AffiniPure Goat Anti-Rabbit IgG (H+L).
    • Overlay histogram showing A549 cells stained with CSB-RA240595A0HU (red line) at 1:50. The cells were fixed with 70% Ethylalcohol (18h) and then incubated in 10% normal goat serum to block non-specific protein-protein interactions followedby the antibody (1μg/1*106 cells) for 1 h at 4℃.The secondary antibody used was FITC-conjugated goat anti-rabbit IgG (H+L) at 1/200 dilution for 30min at 4℃. Control antibody (green line) was Rabbit IgG (1μg/1*106 cells) used under the same conditions. Acquisition of >10,000 events was performed.
  • 其他:

產品詳情

  • 產品描述:
    CSB-RA240595A0HU FASN重組單克隆抗體是針對脂肪酸合酶(FASN)開發的高特異性科研試劑。FASN是催化長鏈脂肪酸合成的關鍵限速酶,在脂質代謝調控中發揮核心作用,其異常表達與腫瘤發生、代謝性疾病等病理過程密切相關。本產品通過重組技術制備,經ELISA、免疫熒光(IF)及流式細胞術(FC)嚴格驗證,在推薦稀釋比例(IF:1:20-1:200,FC:1:20-1:200)范圍內展現出優異的抗原結合能力與批次穩定性。實驗數據顯示,該抗體能精準識別天然構象下的FASN蛋白,適用于活細胞或固定樣本的亞細胞定位分析以及細胞表面蛋白豐度檢測。在科研領域,該試劑可廣泛應用于腫瘤細胞代謝研究、脂質合成通路解析、藥物靶點篩選等方向,特別適合用于體外培養細胞模型的蛋白功能研究、代謝重編程機制探索及小分子抑制劑作用效果評估等實驗場景。其卓越的檢測性能為揭示FASN在疾病發生發展中的分子機制提供了可靠工具。
  • Uniprot No.:
  • 基因名:
  • 別名:
    Fatty acid synthase (EC 2.3.1.85) [Includes: [Acyl-carrier-protein] S-acetyltransferase (EC 2.3.1.38), [Acyl-carrier-protein] S-malonyltransferase (EC 2.3.1.39), 3-oxoacyl-[acyl-carrier-protein] synthase (EC 2.3.1.41), 3-oxoacyl-[acyl-carrier-protein] reductase (EC 1.1.1.100), 3-hydroxyacyl-[acyl-carrier-protein] dehydratase (EC 4.2.1.59), Enoyl-[acyl-carrier-protein] reductase (EC 1.3.1.39), Oleoyl-[acyl-carrier-protein] hydrolase (EC 3.1.2.14)], FASN, FAS
  • 反應種屬:
    Human
  • 免疫原:
    A synthesized peptide derived from human FASN
  • 免疫原種屬:
    Homo sapiens (Human)
  • 標記方式:
    Non-conjugated
  • 克隆類型:
    Monoclonal
  • 抗體亞型:
    Rabbit IgG
  • 純化方式:
    Affinity-chromatography
  • 克隆號:
    2A5
  • 濃度:
    It differs from different batches. Please contact us to confirm it.
  • 保存緩沖液:
    Rabbit IgG in 10mM phosphate buffered saline , pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol.
  • 產品提供形式:
    Liquid
  • 應用范圍:
    ELISA, IF, FC
  • 推薦稀釋比:
    Application Recommended Dilution
    IF 1:20-1:200
    FC 1:20-1:200
  • Protocols:
  • 儲存條件:
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 貨期:
    Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
  • 用途:
    For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產品評價

靶點詳情

  • 功能:
    Fatty acid synthetase is a multifunctional enzyme that catalyzes the de novo biosynthesis of long-chain saturated fatty acids starting from acetyl-CoA and malonyl-CoA in the presence of NADPH. This multifunctional protein contains 7 catalytic activities and a site for the binding of the prosthetic group 4'-phosphopantetheine of the acyl carrier protein ([ACP]) domain.
  • 基因功能參考文獻:
    1. Evaluation of FAS/FASL polymorphisms can predict lack of response to BCG immunotherapy and prevent the loss of valuable time before such alternative treatments as early cystectomy are initiated. PMID: 29453645
    2. FASN-induced S6 kinase facilitates USP11-eIF4B complex formation for sustained oncogenic translation in diffuse large B-cell lymphoma. PMID: 29483509
    3. HIV-1 infection increases intracellular levels of fatty acid synthase (FASN). Despite the requirement of FASN for nascent virion production, FASN activity was not required for intracellular Gag protein production, indicating that FASN dependent de novo fatty acid biosynthesis contributes to a late step of HIV-1 replication PMID: 28962653
    4. Findings showed that FASN is upregulated in colorectal cancer cell lines that overexpress PGC-1alpha and indicated that FASN expression may enhance cancer cell proliferation by regulating antioxidant enzyme production and resistance to ROS-induced apoptosis. Further data provided evidence that FASN expression was regulated indirectly by PGC-1alpha. PMID: 29130104
    5. Repression of FAS mRNA expression is the consequence of feedback inhibition of FAS expression by long chain fatty acyl-CoAs, which are formed by FACL3 during its upregulation by vitamin D3 in prostate cancer cells. PMID: 15556626
    6. analysis of the expression of fatty acid synthase, Ki-67 and p53 in squamous cell carcinomas of the larynx PMID: 18949744
    7. Fatty acid synthase (FASN) mRNA and protein overexpression were associated with unfavorable clinicopathologic factors and poor outcomes. PMID: 28442505
    8. KRAS is associated with activation of ERK2, induction of FASN, and promotion of lipogenesis. PMID: 28400509
    9. The study has shown that the high frequency of FASN expression in intraepithelial neoplasia (hPIN)and cancer and no expression in most structures of benign hyperplasia make it possible to use this protein as an additional marker in the differential diagnosis of prostatic neoplasms. PMID: 28418352
    10. FASN inhibition/knockdown significantly increased the susceptibility of cisplatin-resistant cells to NK cell cytotoxicity. PMID: 29306075
    11. FASN has a role in leucine deprivation-inhibited proliferation and apoptosis of human breast cancer cells PMID: 27579768
    12. HER2-FASN lipogenic axis delineates a group of breast cancer patients that might benefit from treatment with therapeutic regimens containing FASN inhibitors PMID: 27714708
    13. FASN expression is down-regulated by miR-15a and miR-16-1 in breast cancer cells, regulating cell proliferation. PMID: 27713175
    14. These findings implicate Spot14 as a direct protein enhancer of FASN catalysis in the mammary gland during lactation when maximal MCFA production is needed. PMID: 24771867
    15. High FASN expression is associated with prostate cancer growth. PMID: 26934656
    16. We show that elevated levels of PPARG strongly correlate with elevation of FASN in human prostate cancer (CaP) and that high levels of PPARG/FASN and PI3K/pAKT pathway activation confer a poor prognosis.These data suggest that CaP patients could be stratified in terms of PPARG/FASN and PTEN levels to identify patients with aggressive CaP who may respond favorably to PPARG/FASN inhibition. PMID: 27357679
    17. High FASN expression is associated with meningioma and schwannoma. PMID: 28729415
    18. our findings show that microRNA-195 inhibits pancreatic cancer cell proliferation and invasion by regulating the fatty acid synthase/Wnt signaling pathway, suggesting a tumor suppressive role for microRNA-195 in the development and progression of pancreatic cancer. Thus, inhibiting fatty acid synthase by microRNA-195 may serve as a novel therapeutic approach for the treatment of pancreatic cancer. PMID: 28639885
    19. Inhibition of FASN can decrease the levels of IGFBP1, and the expression, activity, and ubiquitination of HIF-1alpha. Inhibition of FASN can suppress migration, invasion and healing of hepatoma carcinoma cells by decreasing HIF-1alpha, and IGFBP1. PMID: 28197637
    20. The involvement of SREBP-1c and ChREBP in FASN promoter histone modification.Histone acetylation affects FASN transcription by influencing ChREBP-binding carbohydrate-responsive elements. PMID: 28027934
    21. Fatty acid synthase (FASN) inhibitors reduce proliferation and promote apoptosis in high FASN producers lymphatic endothelial cells (HDLEC) cells. PMID: 27918556
    22. MACC1 and FASN are positively correlated and responsible for the poor prognoses in gastric cancer patients.FASN role in gastric cancer resistance to oxaliplatin. PMID: 28339092
    23. Fatty acid synthase fine-tunes the cell's response to stress and injury by remodeling cellular O-GlcNAcylation PMID: 28232487
    24. B7-H3 hijacks SREBP-1/FASN signaling mediating abnormal lipid metabolism in lung cancer PMID: 27939887
    25. Uterine leiomyomata risk was positively associated with FASN AA genotype of SNP rs4247357 among the 7% of African American women with >40% European ancestry. PMID: 27375065
    26. DNA methylation in HIF3A shares moderate correlation between adipose tissue and blood, and both are associated with BMI. In contrast, methylation in FASN is poorly correlated across tissues, but the DNA methylation in adipose tissue but not blood is highly associated with BMI PMID: 26891033
    27. the present study provided evidence that miR320 may directly target fatty acid synthase. These results suggest that miR320 may serve as a therapeutic biomarker of NSCLC in the future. PMID: 27277534
    28. increased expression of NF-YA may promote a malignant phenotype in OS cells via modulation of FASN expression. PMID: 27840951
    29. Results suggest investigation of combined fatty acid synthase (FASN) inhibition and taxane treatment as a therapy for a variety of cancers. PMID: 28159572
    30. our study suggests that miR12075p/FASN plays an important role in hepatocellular carcinoma PMID: 27461404
    31. Our observations suggest a physiological role of placental FASN in human pregnancy. Future studies will clarify whether circulating FASN of placental origin does actually regulate placental and fetal growth PMID: 27090298
    32. Results suggest that FASN plays a pivotal role in glioma neovascularization, and inhibition of FASN may be a potential target for anti-angiogenic therapy for glioma. PMID: 27601165
    33. The role of FASN in breast cancer [review] PMID: 26951539
    34. FASN, ErbB2-high-expressing SK-BR-3 cells displayed higher levels of glycolysis and migration than FASN, ErbB2-low-expressing MCF7 cells. PMID: 26936618
    35. S-nitrosylation of FAS at normal physiological levels of NO increases its activity through dimerization and may contribute to the proper regulation of adipogenesis PMID: 26851298
    36. concluded that EGFR can be activated intracellularly by FASN-dependent palmitoylation PMID: 26378037
    37. Our results suggest that FASN upregulation and PTEN downregualtion may be involved in peritoneal dissemination for gastric cancer progression. PMID: 26514456
    38. Data suggest that thioesterase 2 (TE2) catalytic domain of FASN exhibits novel capping domain insert within the alpha/beta hydrolase core; TE2 (as opposed to TE1 domain) readily releases short chain fatty acids from full-length FASN during turnover. PMID: 26663084
    39. data demonstrate that selective and potent FASN inhibition with TVB-3166 leads to selective death of tumor cells, without significant effect on normal cells, and inhibits in vivo xenograft tumor growth at well-tolerated doses. PMID: 26425687
    40. Results showed correlated FASN regulation relative to key signaling genes with tumor invasion and differentiation in primary retinoblastoma (RB) tissues. Its silencing exerted definite anti-cancer effects in RB cells through PI3K/AKT signaling pathway. PMID: 25958981
    41. Findings indicate that overexpression of FASN plays a crucial role in maintaining energy homeostasis in CRC via increased oxidation of endogenously synthesized lipids. PMID: 25970773
    42. TG levels are regulated by HCBP6-sterol regulatory element binding protein 1c (SREBP1c)-mediated fatty acid synthase (FASN) expression. PMID: 25855506
    43. Loss of fatty acid synthase suppresses the malignant phenotype of colorectal cancer cells by down-regulating energy metabolism and mTOR signaling pathway. PMID: 26109148
    44. In the present study it was determined whether three key enzymes for glycolysis, glutaminolysis and de novo synthesis of FAs, hexokinase-2, glutaminase and fatty acid synthase PMID: 26134042
    45. FASN and HER2 have roles in breast cancer and are blocked by EGCG with pertuzumab or temsirolimus PMID: 26107737
    46. Overall, no SNPs were associated with any known aggressiveness indicators. FASN staining intensity was stronger in malignant than in benign tissue, and NADT was associated with decreased FASN staining in both benign and malignant tissue PMID: 25868764
    47. The results suggested that differential levels of P-glycoprotein, Caveolin-1 and Fatty acid synthase except CYP450 play a major role in acquired resistant phenotype in bladder cancer. PMID: 26025399
    48. FASN inhibition induced apoptosis in chemosensitive and platinum-resistant ovarian cancer cells and may reverse cisplatin resistance. PMID: 25947066
    49. These results for the first time indicated that a cross talk in FASN and HER2 expressions might be associated with prognosis in malignant ovarian cancer. PMID: 25433947
    50. The results reveal that the cytotoxic effects of FASN inhibitors in sensitive lines may be due to the robust depletion of oncogenic signaling lipids, such as diacylglycerols and the elevation of tumor-suppressing ceramides. PMID: 25871544

    顯示更多

    收起更多

  • 亞細胞定位:
    Cytoplasm. Melanosome. Note=Identified by mass spectrometry in melanosome fractions from stage I to stage IV.
  • 組織特異性:
    Ubiquitous. Prominent expression in brain, lung, liver and mammary gland.
  • 數據庫鏈接:

    HGNC: 3594

    OMIM: 600212

    KEGG: hsa:2194

    STRING: 9606.ENSP00000304592

    UniGene: Hs.83190



主站蜘蛛池模板: 青青热久免费精品视频| 69成人免费视频无码专区| 欧美大胆作爱视频欣赏人体| 日韩人妻少妇一区二区| 猫咪www免费人成人入口| 国产精品无码av无码| 国产无遮挡色视频免费观看性色| 狠狠色噜噜狠狠狠狠色综合网| 狠狠色狠狠色综合| 欧美私人情侣网站| 国内精品久久久久影院免费| 日本一区不卡高清更新二区| 国产精品久久久久久超碰| 白嫩日本少妇做爰| 久久www成人免费网站| 人妻三级日本香港三级极97| 欧洲熟妇精品视频| 国产私拍大尺度在线视频| 久久久精品妇女99| 国产亚洲欧美日韩俺去了| 国内精品人妻久久毛片app| 亚洲精品55夜色66夜色| 亚洲 日韩 国产 有码 不卡| 疯狂三人交性欧美| 中文字幕av在线一二三区| 在线观看成人年视频免费| 国产成人av大片在线播放| 国产精品后入内射日本在线观看| 亚洲妇女水蜜桃av网网站| 爆乳一区二区三区无码| 内射精品无码中文字幕| 国内揄拍国内精品少妇国语| 神马午夜福利不卡片在线| 久久久久久久综合日本| 少妇性饥渴无码a区免费| 性强烈的欧美三级视频| 久久久精品中文字幕乱码18| 亚洲v欧美v国产v在线观看| 内射人妻无套中出无码| 在线视频免费无码专区| 最近2019免费中文第一页|